Research degree in "personalising medical therapy in Crohn's disease".
Interest in database research and review of clinical, endoscopic, radiologic and biochemical factors.
Further laboratory-based research in metabonomics at South Kensington.
- Supervision of two research students: BSc and MRes.
- Consultant Gastroenterologist
- Head of IBD Clinical Trials Unit
Gilmore R, Tassone D, Ding NS, 2023, Letter: tofacitinib in the real world - do clinical trial data stand up?, Aliment Pharmacol Ther, Vol:57, Pages:745-746
et al., 2023, ECCO Topical Review on Biological Treatment Cycles in Crohn's Disease, Journal of Crohns & Colitis, ISSN:1873-9946
et al., 2022, Systematic review: the impact and importance of body composition in inflammatory bowel disease, Journal of Crohns & Colitis, ISSN:1873-9946
Tassone D, Singh S, Sheng Ding N, 2021, Editorial: impact of body mass index on clinical outcomes in patients with ulcerative colitis treated with tofacitinib, Alimentary Pharmacology & Therapeutics, Vol:54, ISSN:0269-2813, Pages:206-207
et al., 2021, Systematic review: efficacy of escalated maintenance anti-tumour necrosis factor therapy in Crohn's disease, Alimentary Pharmacology & Therapeutics, Vol:54, ISSN:0269-2813, Pages:249-266